Featured Research

from universities, journals, and other organizations

Need relief from asthma? Communicating with your allergist is key

Date:
January 13, 2014
Source:
American College of Allergy, Asthma and Immunology (ACAAI)
Summary:
Can’t find relief from your asthma symptoms? The way you communicate with your allergist can be the root of your problems. According to two papers published, in order for treatment to be effective, asthma sufferers need to ask questions and feel as if they have open communication with their allergist.

Can't find relief from your asthma symptoms? The way you communicate with your allergist can be the root of your problems. According to two papers published in the January issue of Annals of Allergy, Asthma and Immunology, in order for treatment to be effective, asthma sufferers need to ask questions and feel as if they have open communication with their allergist.

"When patients do not understand their condition or treatment plan, they may not follow life-saving guidelines, putting them at increased risk for asthma attacks," said allergist Stanley Fineman, MD, past-president of the American College of Allergy, Asthma and Immunology (ACAAI) and article author. "Changes need to be made by allergists and patients to ensure a treatment plan is in place that will be followed. Proper treatment and adherence to the plan not only improves quality of life, but may save lives."

In his paper, Dr. Fineman noted that only eight to 13 percent of asthma sufferers continue to refill inhaled corticosteroid prescriptions after one year. Taken early and as directed, these inhalers can improve asthma control, normalize lung function and even prevent irreversible injury to airways.

Asthma is responsible for 4,000 deaths annually, according to ACAAI. The number of Americans with asthma grows every year, and currently affects 26 million Americans. The greatest rise in asthma rates is among African American children, which doubled from 2001 to 2009.

A second paper found young African American adults are particularly at risk for not following treatment plans due to communication barriers and age. They also reported feeling uncomfortable taking their medication in public settings.

"Our research found many African American asthma sufferers believed they had a better understanding of their asthma triggers and treatment as they reached young adulthood," said allergist Alan Baptist, MD, MPH ACAAI member and senior study author. "However, many do not manage their condition as advised, which can lead to increased asthma attacks and emergency room visits. Allergists need to communicate the importance of continuing medication, and patients should express any concerns they might have, such as taking medication in public, since there are often solutions. Additionally, providing adequate education and addressing specific barriers that young African American adults have in asthma management may decrease health care disparities and improve outcomes."

In this small study of 34 young adults, many of these asthma sufferers said they stopped using prescribed medication when symptoms subsided, which is a common problem among asthma sufferers nationwide.

Although symptoms can become better with time, asthma is a chronic illness. Unless directed by a physician, asthma patients should never change or discontinue preventive medications, and should always keep an adequate supply available.

"Asthma is a serious disease and discontinuing treatment can be dangerous," said Dr. Fineman. "Sufferers need to be sure they regularly take medication and that all of their concerns are being addressed."


Story Source:

The above story is based on materials provided by American College of Allergy, Asthma and Immunology (ACAAI). Note: Materials may be edited for content and length.


Journal References:

  1. Marissa R. Shams, Stanley M. Fineman. Asthma adherence: how can we help our patients do it better? Annals of Allergy, Asthma & Immunology, 2014; 112 (1): 9 DOI: 10.1016/j.anai.2013.10.013
  2. Aimee L. Speck, Belinda Nelson, S. Olivia Jefferson, Alan P. Baptist. Young, African American adults with asthma: what matters to them? Annals of Allergy, Asthma & Immunology, 2014; 112 (1): 35 DOI: 10.1016/j.anai.2013.10.016

Cite This Page:

American College of Allergy, Asthma and Immunology (ACAAI). "Need relief from asthma? Communicating with your allergist is key." ScienceDaily. ScienceDaily, 13 January 2014. <www.sciencedaily.com/releases/2014/01/140113095139.htm>.
American College of Allergy, Asthma and Immunology (ACAAI). (2014, January 13). Need relief from asthma? Communicating with your allergist is key. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/01/140113095139.htm
American College of Allergy, Asthma and Immunology (ACAAI). "Need relief from asthma? Communicating with your allergist is key." ScienceDaily. www.sciencedaily.com/releases/2014/01/140113095139.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins